Table 3 Association between one or more children histocompatible from the mother’s perspective among systemic lupus erythematosus (SLE) cases compared to controls (analyses are for each HLA locus and are adjusted for number of live births)

From: Mother−child histocompatibility and risk of rheumatoid arthritis and systemic lupus erythematosus among mothers

Any histocompatible children

SLE

n (%)

Controls

n (%)

OR (95% CI)

Bonferroni corrected p valuea

HLA Class I

 A

None

78 (67)

683 (75)

Reference

 

1 or more

39 (33)

230 (25)

1.5 (1.0–2.3)

0.35

 B

None

101 (86)

814 (89)

Reference

 

1 or more

16 (14)

99 (11)

1.2 (0.7–2.2)

1.00

 C

None

92 (79)

752 (82)

Reference

 

1 or more

25 (21)

161 (18)

1.2 (0.7–1.9)

1.00

HLA Class II

 DPB1

None

64 (55)

555 (61)

Reference

 

1 or more

53 (45)

358 (39)

1.3 (0.9–1.9)

1.00

 DQA1

None

69 (59)

597 (65)

Reference

 

1 or more

48 (41)

316 (35)

1.2 (0.8–1.9)

1.00

 DQB1

None

85 (73)

725 (79)

Reference

 

1 or more

32 (27)

188 (21)

1.4 (0.9–2.1)

1.00

 DRB1

None

103 (75)

765 (84)

Reference

 

1 or more

35 (25)

148 (16)

1.3 (0.8–2.2)

1.00

  1. OR odds ratio, 95% CI confidence interval
  2. aBonferroni corrected p values for seven tests